Emmett L, Papa N, Subramaniam S, Crumbaker M, et al. Prognostic and predictive value of baseline PSMA-PET total tumour volume and SUVmean in metastatic castration-resistant prostate cancer in ENZA-p (ANZUP1901): a substudy from a multicentre, open-label, randomised, phase 2 trial. Lancet Oncol 2025 Jul 30:S1470-2045(25)00339.
PMID: 40752515